Thalassaemia

Thalassaemia is an inherited blood disorder characterized by reduced or abnormal production of hemoglobin, causing the body to destroy red blood cells faster than it can produce them and resulting in chronic anaemia. It occurs when genetic mutations disrupt the normal production of alpha or beta globin chains that make up hemoglobin. Severity ranges from a mild, symptomless trait to severe, transfusion-dependent forms requiring lifelong medical management. The condition is particularly prevalent in populations from the Mediterranean, Middle East, South Asia, and Southeast Asia.

The most common symptoms include: Chronic fatigue and weakness; pale or yellowish skin; slow growth in children; bone deformities especially in the face. Early recognition is key to prompt diagnosis and effective treatment.

No, Thalassaemia is not contagious. It cannot spread through casual contact. However, certain risk factors and genetic predispositions may increase susceptibility.

Treatment options include: Mild forms may require no treatment beyond monitoring; while moderate to severe forms require regular blood transfusions to maintain adequate hemoglobin levels; combined with iron chelation therapy to prevent organ damage from iron overload. Bone marrow or stem cell transplantation can be curative in select severe cases. Treatment should always be guided by a qualified Hematology specialist. Do not self-medicate.

While Thalassaemia cannot always be fully prevented, several measures can reduce risk: Genetic counseling and carrier screening before marriage or pregnancy in high-risk populations; prenatal testing for at-risk couples; avoiding unnecessary iron supplementation without testing.

Seek immediate medical attention if you experience symptoms of Thalassaemia. This is a serious condition — go to the emergency room or call 112 if symptoms are severe or rapidly worsening.